Thank you very much from a fellow Desi,great to read your bullet points and viewed all the slides. I guess LL not giving us any more information on any pending PR will have to wait and see what happens Monday thank you again Dr. Bala. I appreciate it.
Thanks. I think slide 10 of 34 has the reference to the 47% alive at 3 years ... in Phase I/II (n=23)
Whereas it shows Stupp at 20%.
And I believe the blinded data for our n=331 showed 28.2% ... and one would assume it would be a bit worse for those in the control group, and the percentage would be a bit better for treatment group cohort.
Yes I listened to Dr Liau too yesterday. She didn't have much to say about when topline results would be available. She was specifically asked that question near the end of her talk and said something like they are working on the data analysis and it will be available when it is available.
She was funny as she talked about the history and evolution of immunotherapy for GBM in that several times she said that if she knew 20 years ago it was going to take this long to move from animal trials to human she would have done something else :-)